ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.
ETFOptimize | HOME
Close Window
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Scientist.com Named America’s 11th Most Innovative Company by Fortune

By: via Business Wire

Unique business to enterprise (B2E) marketplace is transforming how preclinical research is done by the pharmaceutical and biotechnology industries

Scientist.com, the premier R&D marketplace for the biopharmaceutical industry, announced it has been named by Fortune as America’s 11th Most Innovative Company. The company was recognized as the 5th Most Innovative Company in California and as America’s 8th Most Innovative Company in the Technology sector.

“What connects groundbreaking scientific advancements, a dynamic company culture, and a steadfast dedication to fostering novel ideas and solutions?” asked Kevin Lustig, PhD, Founder and CEO at Scientist.com. “The answer is innovation. Since its inception, Scientist.com has been driven by a passion for innovation, aiming to transform the scientific research landscape and enable more effective collaboration among researchers worldwide.”

Fortune, in partnership with market research and data company Statista, reviewed over 15,000 eligible companies to create the list. Each company was assessed in three areas: Product Innovation, Process Innovation, and Innovation Culture. Companies that made the list are a who’s who of disruptive companies that have become household names, including Alphabet, Microsoft, IBM, Salesforce, Dell, Amazon, and Tesla, among others. Scientist.com ranked third among all companies in both Process Innovation and Innovation Culture categories.

“Scientist.com has created a solution to some of the biggest problems facing biopharma research organizations today, including a decline in R&D efficiency and the rising cost of bringing new drugs to market,” said Chris Petersen, Founder and CTO at Scientist.com. “By eliminating paperwork and bureaucracy and creating a more automated and intelligent R&D process, Scientist.com is helping drive tomorrow’s great discoveries, today.”

Scientist.com was recently recognized as the “Overall BioPharma Solution of the Year” in the 2022 BioTech Breakthrough Awards. The company was also named to Inc. magazine’s “Honor Roll” for being one of the fastest-growing private companies in America five consecutive years, from 2017-2021, ranking as high as #9.

About Scientist.com

Scientist.com's mission is to empower and connect scientists worldwide. The company's digital research platform combines a custom-built, cloud native technology stack with white-glove customer and scientific support to enable scientists to run more innovative experiments in less time and at lower cost. Scientist.com leverages internally developed machine learning models to provide actionable insights that improve operational efficiency and effective research management. Scientist.com connects the world's top pharmaceutical companies, biotechnology companies and the US National Institutes of Health (NIH) to the world's largest network of scientific suppliers.

Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.


 
IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.